Luminex Corp. (LMNX)

20.32
0.51 2.57
NASDAQ : Health Technology
Prev Close 19.81
Open 19.60
Day Low/High 19.60 / 20.47
52 Wk Low/High 17.34 / 30.16
Volume 353.85K
Avg Volume 183.90K
Exchange NASDAQ
Shares Outstanding 45.05M
Market Cap 899.69M
EPS 0.40
P/E Ratio N/A
Div & Yield 0.36 (1.34%)

Latest News

Luminex Corporation Reports Third Quarter 2019 Results And Submission Of VERIGENE II Gastrointestinal Flex Assay To The FDA

Luminex Corporation Reports Third Quarter 2019 Results And Submission Of VERIGENE II Gastrointestinal Flex Assay To The FDA

AUSTIN, Texas, Nov. 4, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019.

Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019

Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019

AUSTIN, Texas, Oct. 25, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2019 on Monday, November 4, 2019 after the market close.

Luminex Receives FDA 510(k) Clearance For The ARIES® MRSA Assay

Luminex Receives FDA 510(k) Clearance For The ARIES® MRSA Assay

AUSTIN, Texas, Oct. 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company has received U.

Luminex Corporation To Present At The Cantor Global Healthcare Conference On October 2, 2019

Luminex Corporation To Present At The Cantor Global Healthcare Conference On October 2, 2019

AUSTIN, Texas, Sept. 26, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, and Harriss Currie, Senior Vice President of Finance and CFO, will participate in investor meetings...

Luminex Corporation To Present At The Morgan Stanley 17th Annual Global Healthcare Conference

Luminex Corporation To Present At The Morgan Stanley 17th Annual Global Healthcare Conference

AUSTIN, Texas, Sept. 3, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 17th Annual Global Healthcare...

Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend

Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend

AUSTIN, Texas, July 31, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the second quarter 2019.

Luminex Becomes Oversold (LMNX)

Luminex Becomes Oversold (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Luminex Corporation Second Quarter Earnings Release Scheduled For July 31, 2019

Luminex Corporation Second Quarter Earnings Release Scheduled For July 31, 2019

AUSTIN, Texas, July 11, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019.

Luminex Submits ARIES MRSA Assay For FDA Clearance

Luminex Submits ARIES MRSA Assay For FDA Clearance

AUSTIN, Texas, July 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company submitted the ARIES® MRSA Assay to the U.

EDP Biotech To Develop And Market Colorectal Cancer Early Detection Blood Test Using Luminex XMAP® Technology

EDP Biotech To Develop And Market Colorectal Cancer Early Detection Blood Test Using Luminex XMAP® Technology

Multiplexed immunoassay technology, coupled with machine learning, provides more data per patient and an accurate picture of that individual's disease.

Luminex Is Now Oversold (LMNX)

Luminex Is Now Oversold (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Luminex Enters Oversold Territory (LMNX)

Luminex Enters Oversold Territory (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of April 2019 Options Trading For Luminex (LMNX)

First Week Of April 2019 Options Trading For Luminex (LMNX)

Investors in Luminex Corp saw new options begin trading this week, for the April 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 115 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Luminex Enters Oversold Territory (LMNX)

Luminex Enters Oversold Territory (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: OCSI Downgrades: CIEN, CIR, CORE, EBIX, EFII, KOS, LMNX, LOB, SPAR, SRCI, STAA, VEC Initiations: CCT, CEIX Read on to get TheStreet Quant Ratings' detailed report:

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $27.33, changing hands for $27.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

XCR Diagnostics And Luminex Enter Into License Agreement

XCR Diagnostics And Luminex Enter Into License Agreement

Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR's proprietary Xtreme Chain Reaction nucleic acid amplification technology.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $27.50, changing hands for $27.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ex-Dividend Reminder: Luminex, Hill-Rom Holdings And Republic Bancorp

Ex-Dividend Reminder: Luminex, Hill-Rom Holdings And Republic Bancorp

Looking at the universe of stocks we cover at Dividend Channel, on 9/20/18, Luminex Corp , Hill-Rom Holdings, Inc. , and Republic Bancorp, Inc.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $27.50, changing hands for $27.77/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week Of LMNX January 2019 Options Trading

Investors in Luminex Corp saw new options become available this week, for the January 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Luminex Stock Sees Short Interest Decrease By 10.6%

Luminex Stock Sees Short Interest Decrease By 10.6%

The most recent short interest data has been released for the 02/28/2018 settlement date, which shows a 352,489 share decrease in total short interest for Luminex Corp , to 2,976,432, a decrease of 10.59% since 02/15/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.80, changing hands for $21.06/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Luminex is Now Oversold (LMNX)

Luminex is Now Oversold (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LMNX Makes Notable Cross Below Critical Moving Average

LMNX Makes Notable Cross Below Critical Moving Average

In trading on Tuesday, shares of Luminex Corp crossed below their 200 day moving average of $20.36, changing hands as low as $20.28 per share. Luminex Corp shares are currently trading down about 0.7% on the day.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ex-Dividend Reminder: Luminex, DCT Industrial Trust and CYS Investments

Ex-Dividend Reminder: Luminex, DCT Industrial Trust and CYS Investments

Looking at the universe of stocks we cover at Dividend Channel, on 12/21/17, Luminex Corp , DCT Industrial Trust Inc , and CYS Investments, Inc. will all trade ex-dividend for their respective upcoming dividends.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DLHC, ERI, FARM, GLRE, HCLP, HFC, HRZN, LMNX, WEX, ZAGG Downgrades: BDC, CWCO, HRTG, TLGT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: C- (Hold)